Golden Royal Development Inc.

2022 Q4 Form 10-Q Financial Statement

#000149315223007611 Filed on March 14, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q4

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets $0.00 $0.00
Total Assets
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $89.75K $87.98K
YoY Change 57.8%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $206.3K $197.7K
YoY Change 47.05%
SHAREHOLDERS EQUITY
Retained Earnings -$236.6K -$228.0K $178.8K
YoY Change -232.36% 31.02% -226.31%
Common Stock $78.00 $78.00
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$206.3K -$197.7K -$148.5K
YoY Change
Total Liabilities & Shareholders Equity
YoY Change

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q4

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 dei Entity Central Index Key
EntityCentralIndexKey
0001761534
CY2022Q4 dei Amendment Flag
AmendmentFlag
false
CY2022Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2022Q4 us-gaap Assets Current
AssetsCurrent
usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
usd
CY2022Q4 us-gaap Assets
Assets
usd
CY2022Q3 us-gaap Assets
Assets
usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2021Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
usd
CY2022Q4 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
usd
CY2021Q4 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2021Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021Q4 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2022Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2021Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2022Q4 dei Document Type
DocumentType
10-Q
CY2022Q4 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q4 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022Q4 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q4 dei Entity File Number
EntityFileNumber
0-56017
CY2022Q4 dei Entity Registrant Name
EntityRegistrantName
GOLDEN ROYAL DEVELOPMENT INC.
CY2022Q4 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q4 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-4563277
CY2022Q4 dei Entity Address Address Line1
EntityAddressAddressLine1
80 Main Street
CY2022Q4 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 415
CY2022Q4 dei Entity Address City Or Town
EntityAddressCityOrTown
West Orange
CY2022Q4 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2022Q4 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07052
CY2022Q4 dei City Area Code
CityAreaCode
800
CY2022Q4 dei Local Phone Number
LocalPhoneNumber
320-4394
CY2022Q4 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q4 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q4 dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022Q4 dei Entity Small Business
EntitySmallBusiness
true
CY2022Q4 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022Q4 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7841550 shares
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
89746 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
87984 usd
CY2022Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
5000 usd
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
4700 usd
CY2022Q4 us-gaap Bank Overdrafts
BankOverdrafts
522 usd
CY2022Q3 us-gaap Bank Overdrafts
BankOverdrafts
248 usd
CY2022Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
111070 usd
CY2022Q3 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
104734 usd
CY2022Q4 us-gaap Liabilities
Liabilities
206338 usd
CY2022Q3 us-gaap Liabilities
Liabilities
197666 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7841550 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7841550 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7841550 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7841550 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
78 usd
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
78 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30222 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
30222 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-236639 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-227967 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-206338 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-197666 usd
CY2022Q4 us-gaap Professional Fees
ProfessionalFees
6588 usd
CY2021Q4 us-gaap Professional Fees
ProfessionalFees
8613 usd
CY2022Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2084 usd
CY2021Q4 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5547 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
8672 usd
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
14160 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-8672 usd
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-14160 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8672 usd
CY2021Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14160 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-8672 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-14160 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7841550 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7841550 shares
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-197666 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-8672 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-206338 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-134326 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-134326 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-14160 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-14160 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-148486 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-148486 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-8672 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
-14160 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
300 usd
CY2021Q4 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
300 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1762 usd
CY2021Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10411 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6610 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3449 usd
CY2022Q4 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
274 usd
CY2021Q4 us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
1488 usd
CY2022Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
7217 usd
CY2021Q4 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
1954 usd
CY2022Q4 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
881 usd
CY2021Q4 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
90 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6610 usd
CY2021Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3352 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-97 usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
97 usd
CY2022Q4 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_840_eus-gaap--UseOfEstimates_zcRhq1sl7CJ3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span style="text-decoration: underline">(B) <span id="xdx_86E_zoDVqDfIA7Jb">Use of Estimates</span></span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2022Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2021Q4 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2022Q4 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
300 usd
CY2021Q4 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
1540 usd
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
7217 usd
CY2022Q4 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
881 usd
CY2022Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
111070 usd
CY2022Q3 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
104734 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
1954 usd
CY2021Q4 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
90 usd
CY2022Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
300 usd
CY2021Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
300 usd
CY2022Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
5000 usd
CY2022Q3 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
4700 usd
CY2017Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2017Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7841550 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7841550 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
7841550 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
7841550 shares
CY2023Q1 us-gaap Area Of Land
AreaOfLand
80 acre
CY2022Q4 us-gaap Asset Impairment Charges
AssetImpairmentCharges
300 usd
CY2021Q4 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-8672 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6610 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-236639 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-206338 usd
CY2022Q4 GRDV Working Capital
WorkingCapital
-206338 usd

Files In Submission

Name View Source Status
0001493152-23-007611-index-headers.html Edgar Link pending
0001493152-23-007611-index.html Edgar Link pending
0001493152-23-007611.txt Edgar Link pending
0001493152-23-007611-xbrl.zip Edgar Link pending
ex31.htm Edgar Link pending
ex32.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
grdv-20221231.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
grdv-20221231_pre.xml Edgar Link unprocessable
grdv-20221231_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
grdv-20221231_def.xml Edgar Link unprocessable
grdv-20221231_cal.xml Edgar Link unprocessable